MultiPark: Multidisciplinary research focused on Parkinson´s disease
211 – 220 of 3925
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
The fluorescent ligand bTVBT2 reveals increased p-tau uptake by retinal microglia in Alzheimer’s disease patients and App NL−F/NL−F mice
(
- Contribution to journal › Article
-
Mark
The role of phosphorylation in calmodulin-mediated gating of human AQP0
(
- Contribution to journal › Article
-
Mark
A label-free high-throughput protein solubility assay and its application to Aβ40
(
- Contribution to journal › Article
-
Mark
The annotation of GBA1 has been concealed by its protein-coding pseudogene GBAP1
(
- Contribution to journal › Article
-
Mark
Postmortem imaging reveals patterns of medial temporal lobe vulnerability to tau pathology in Alzheimer’s disease
(
- Contribution to journal › Article
-
Mark
Cognitively defined Alzheimer's dementia subgroups have distinct atrophy patterns
(
- Contribution to journal › Article
- 2023
-
Mark
Environmental barriers and housing accessibility problems for people with Parkinson’s disease : A three-year perspective
(
- Contribution to journal › Article
-
Mark
Gray matter hypoperfusion is a late pathological event in the course of Alzheimer's disease
2023) In Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 43(4). p.565-580(
- Contribution to journal › Article
-
Mark
An accurate fully automated panel of plasma biomarkers for Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Succinate prodrugs as treatment for acute metabolic crisis during fluoroacetate intoxication in the rat
(
- Contribution to journal › Article